Suppr超能文献

从单个肿瘤样本中纯化多种热休克蛋白。

Purification of multiple heat shock proteins from a single tumor sample.

作者信息

Ménoret A, Bell G

机构信息

Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut School of Medicine, Farmington, CT 06030, USA.

出版信息

J Immunol Methods. 2000 Apr 3;237(1-2):119-30. doi: 10.1016/s0022-1759(00)00137-x.

Abstract

Heat shock protein-based vaccines have been shown to immunize against cancer and infectious diseases in both prophylactic and therapeutic protocols. So far, four classes of heat shock proteins (HSPs) preparation: gp96, HSP90 (hsp86, hsp84), HSP70 (hsc70, hsp70) and calreticulin have been used successfully. The methods for purifying them individually are now readily available. However, since tumors are not always available in large quantity, a major challenge remains the development of a procedure to simultaneously isolate these HSPs from the same sample. We report here that hsp40, hsp60, hsc70, hsp70, hsp84, hsp86, and gp96 (grp94) but not BiP (grp78) and calreticulin can be separated from a single tumor sample in one step using heparin-agarose chromatography. Interestingly this procedure separates the HSP70 isoforms hsp70 from hsc70, but not the HSP90 isoforms hsp84 and hsp86. The three main immunogenic HSPs, gp96, hsp86/84, and hsc70 can be further isolated to homogeneity using additional purification methods. In addition, we have shown that the interaction of the chaperoned peptides with hsc70 and gp96 is not compromised during heparin chromatography. These observations provide a new method for preparation of multiple HSP-based vaccines, circumventing the sample size limitation, as well as providing the possibility to study how multiple HSPs can synergize in eliciting immunity.

摘要

基于热休克蛋白的疫苗已在预防和治疗方案中显示出对癌症和传染病具有免疫作用。到目前为止,四类热休克蛋白(HSPs)制剂:gp96、HSP90(hsp86、hsp84)、HSP70(hsc70、hsp70)和钙网蛋白已成功使用。现在已有单独纯化它们的方法。然而,由于肿瘤并非总能大量获取,一个主要挑战仍然是开发一种从同一样本中同时分离这些热休克蛋白的程序。我们在此报告,使用肝素 - 琼脂糖层析法可在一步中从单个肿瘤样本中分离出hsp40、hsp60、hsc70、hsp70、hsp84、hsp86和gp96(grp94),但不能分离出BiP(grp78)和钙网蛋白。有趣的是,该程序可将HSP70异构体hsp70与hsc70分离,但不能分离HSP90异构体hsp84和hsp86。使用额外的纯化方法,三种主要的免疫原性热休克蛋白gp96、hsp86/84和hsc70可进一步纯化至同质。此外,我们已经表明,在肝素层析过程中,伴侣肽与hsc70和gp96的相互作用不会受到影响。这些观察结果提供了一种制备多种基于热休克蛋白的疫苗的新方法,规避了样本量限制,同时也提供了研究多种热休克蛋白如何协同激发免疫的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验